|
|
Article: Cambridge Major Laboratories Dedicates New Large-Scale Active Pharmaceutical Ingredient API Facility.(Company overview)
- Article from:
- Biotech Week
- Article date:
- August 5, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Cambridge Major Laboratories (CML) announces it will be dedicating its new large scale Active Pharmaceutical Ingredient (API) manufacturing facility in Germantown, WI, USA on July 30, 2009. The state-of-the-art facility provides a high quality, US-based API supply option for the pharmaceutical and biotechnology industries, and is in response to CML's need for larger capacity fueled by its growing pipeline of developmental and commercial manufacturing projects (see also Cambridge Major Laboratories).
The facility is designed with six Good Manufacturing Practice (GMP) manufacturing suites capable of producing multi-ton quantities of API's and advanced ...